Two images originating from the lab of Camille Ehre, PhD, and then published in Charles Esther, MD, PhD, and Marianne Muhlebach, MD, et al’s recent paper in Science Translational Medicine were featured on BPoD: Biomedical Picture of the Day on Friday, May 3rd. An archive of the post can be found here. The images were also covered … Read more
Giving mucus-thinning therapies in early childhood might delay the worst symptoms and infections associated with CF, according to a study led by Charles Esther, MD, PhD, and Marianne Muhlebach, MD. Their paper is the cover story of Science Translational Medicine. Read the full news story here and here, and the paper itself here.
Expertscape has recognized Dr. James F. Donohue as a national leader in treating chronic obstructive pulmonary disease. Read the full story here.
A WBTV-Charlotte news segment on “The Dangers of E-Cigarettes and Vaping among Young People” featured studies led by Ilona Jaspers, PhD, focusing especially on the corrosive nature of some of the e-liquids used in e-cigarettes. View the news story here.
The US Department of Defense tabbed UNC Marsico Lung Institute researchers led by Richard Boucher, MD, and Ilona Jaspers, PhD, to study the adverse effects of inhaling toxic fumes from burn pits in the field. Read the full story here.
In a new video, UNC School of Medicine toxicologist Ilona Jaspers, PhD, explains the science of inhaling vapor from e-cigarette products and why we should not compare vaping or “juuling” to smoking. See the video and full article here.
UNC School of Medicine and Duke University researchers, led by Brian Button, PhD, show why coughing can’t force mucus free from airways to help people battle cystic fibrosis and chronic bronchitis, and how new treatments could alter mucus to make coughing more therapeutic. Read the full story here.
James F. Donohue, MD, from the Division of Pulmonary Diseases and Critical Care Medicine, has been recognized in this week’s Carolina Care Highlights. See the full story here.
At the recent North American Cystic Fibrosis Conference in Denver, George Retsch-Bogart, MD, professor of pediatrics and co-director of the UNC Cystic Fibrosis Therapeutics Development Center, received the Cystic Fibrosis Foundation’s 2018 Richard C. Talamo Distinguished Clinical Achievement Award. Read the full story here.
New UNC School of Medicine research led by Martina Gentzsch, PhD, and Carla Ribeiro, PhD, suggests that cystic fibrosis drugs used to correct the faulty CFTR protein would work better when the patients’ airways are inflamed. Read the fully story here.